The medication for the treatment of liver diseases and biliary tract

Consumers survey results of 2013 in category

Digestive system and hepatology / The medication for the treatment of liver diseases and biliary tract

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.		Essentiale Forte N (Sanofi)	39.39%	5

2.	4	Hepabene (ratiopharm)	31.82%	4.11

3.	2	Карсил (Sopharma)	27.27%	3.39

4.	5	Алохол (Борщагівський ХФЗ)	21.21%	2.97

5.	10	Chophytol (Lab. Rosa-Phytopharma)	18.18%	2.28

6.	3	Галстена (Perrigo)	15.15%	2.14

6.	8	Енерлів (Berlin-Chemie Menarini)	15.15%	2.14

8.	7	Antralum (Farmak)	13.64%	1.79

9.		Холосас (Vitaminy)	10.61%	1.50

10.	11	Легалон (Madaus)	7.58%	1.12

11.	9	Дарсіл (Darnitsa)	6.06%	0.83

12.	~	Гепа-Мерц (Merz Pharmaceuticals)	6.06%	0.80

–.	~	~~Гербіон (KRKA)~~	~~3.03%~~	~~0.71~~

13.	~	Артіхол (Київський вітамінний завод)	4.55%	0.67

14.	~	Ліволін Форте (Mega Lifesciences)	4.55%	0.65

14.	~	Силібор (Pharmaceutical company “Zdorovya”)	4.55%	0.65

16.	~	Есслівер Форте (Stada)	3.03%	0.49

17.	~	Холе-гран (Національна гомеопатична спілка)	3.03%	0.47

18.	17	Нукс Воміка (Heel)	3.03%	0.36

19.	6	Лів.52 (Фірма ТК Комфорт)	3.03%	0.33

20.	16	Артишока екстракт Гексал (Sandoz)	3.03%	0.31

20.	~	Биликур (Sandoz)	1.52%	0.31

20.	12	Гепатофіт (Aim)	1.52%	0.31

20.	~	Фламін (Arterium Corporation)	1.52%	0.31

20.	15	Цитраргінін (Zambon France)	1.52%	0.31

25.	~	Гепафорте (Bosnalijek)	1.52%	0.18

25.	12	Силімарин Гексал (Sandoz)	1.52%	0.18

25.	14	Холівер (Hau Giang Ph. JSK-HG Pharm)	1.52%	0.18

28.	~	Берези бруньки (Ternopharm)	1.52%	0.16

28.	15	Гепалекс (Sandoz)	1.52%	0.16

–.		Febichol (Noventis)	0.00%	0

–.		Raphacholin C (Herbapol)	0.00%	0

–.		Бонджигар (Herbion)	0.00%	0

–.		Бренціале Форте (Бринцалов-А)	0.00%	0

–.		Гепарсил (Стиролбіофарм)	0.00%	0

–.		Гепато-флора (Медіфлора)	0.00%	0

–.		Глутаргін (Pharmaceutical company “Zdorovya”)	0.00%	0

–.		Левасіл (Micro Labs)	0.00%	0

–.		ПМ Сірін (N. Kapharma Pharmaceuticals)	0.00%	0

–.		Силімарол (Євролек)	0.00%	0

–.		Симепар (Teva)	0.00%	0

–.	17	Фосфоліп (Universal Medicare)	0.00%	0

–.	17	Холагол (Teva)	0.00%	0

–.	16	Холензим (Belmedpreparaty)	0.00%	0

–.	13	Холензим (Біосинтез)	0.00%	0

–.		Цінарікс (Montavit)	0.00%	0

–.		~~Enterosgelum (Kreoma-Pharm)~~	~~0.00%~~	0

–.		~~Беластезин (Борщагівський ХФЗ)~~	~~0.00%~~	0

–.		~~Дуфалак (Abbott Laboratories)~~	~~0.00%~~	0

–.		~~Ессел Форте (Nabros Pharma)~~	~~0.00%~~	0

–.		~~Уролесан (Arterium Corporation)~~	~~0.00%~~	0

The participant which took the 1st place in this rating is by opinion of Ukrainian consumers is the best choice in 2013, recommendation of consumers #1 in the category “The drug for the treatment of liver diseases and biliary tract”.

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2013, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.